
Principles and clinical applications of interferon-gamma release assays in latent tuberculosis diagnosis
Review article Ha-eun Cho1, Young Jin Kim2 1Department of Laboratory Medicine, Kyung Hee University Hospital, Seoul, Korea2Department of Laboratory Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Korea Correspondence to Young Jin Kim, E-mail: khmclab@gmail.com Ann Clin Microbiol 2025;28(3):17. https://doi.org/10.5145/ACM.2025.28.3.6Received on 7 July 2025, Revised on 4 September 2025, Accepted on 4 September 2025, Published on 20 September 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Latent tuberculosis infection refers to a state in which an individual is infected with Mycobacterium tuberculosis but shows no clinical symptoms. The World Health Organization estimates that 23-25% of the global population has LTBI, which poses a significant public health challenge owing to the risk of progression to active TB. Diagnosis of LTBI involves tests, such as the tuberculin skin test